“Instead, we’re using induced pluripotent stem cells to explore drug potential ... biomarkers related to the onset of adult T-cell leukemia and lymphoma and to develop related testing techniques.

Acute myeloid leukemia (AML) remains incurable for the majority of patients. AML originates from a rare population of cells, termed leukemic stem cells (LSCs) or leukemia-initiating cells ...

Despite recent therapeutic breakthroughs, cancer patients continue to face high recurrence and mortality rates due to treatment resistance. Cancer stem cells (CSCs), a subpopulation with self-renewal ...

HCL uniformly harbors a BRAF mutation that is not present in other B-cell malignancies. Hairy cell leukemia (HCL ... no disease-associated molecular markers have been identified.

Scientists at La Jolla Institute for Immunology (LJI) have discovered how a mutated gene kicks off a dangerous chain of ...

She never met her grandfather who died from leukemia. But being part of the National Marrow Donor Program helped her pay tribute to him.